Clinical Trial Update: Randomized Trial Comparison of Ototoxicity Monitoring Programs [NA]

View source ↗

Summary

Completed randomized trial comparing ototoxicity monitoring programs in patients receiving cisplatin, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cisplatin-induced Ototoxicity
• Hearing Loss

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Cisplatin Ototoxicity, Hearing Loss | NA | Status: COMPLETED | Results posted: 2019-10-09